Does CARFILZOMIB Cause Squamous cell carcinoma? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Squamous cell carcinoma have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.1% of all adverse event reports for CARFILZOMIB.
24
Reports of Squamous cell carcinoma with CARFILZOMIB
0.1%
of all CARFILZOMIB reports
7
Deaths
3
Hospitalizations
How Dangerous Is Squamous cell carcinoma From CARFILZOMIB?
Of the 24 reports, 7 (29.2%) resulted in death, 3 (12.5%) required hospitalization, and 3 (12.5%) were considered life-threatening.
Is Squamous cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARFILZOMIB. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
Which CARFILZOMIB Alternatives Have Lower Squamous cell carcinoma Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL